Hemodynamic and renin responses to (+-)-DOI, a selective 5-HT2 receptor agonist, in conscious rats

European Journal of Pharmacology
R H Alper


The effect of the selective 5-HT2 agonist (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCl (DOI) on arterial pressure (AP), heart rate (HR), renal blood flow (RBF) and plasma renin activity (PRA) was determined in conscious rats. DOI increased AP and PRA, but decreased HR and RBF. All responses to DOI were abolished by central (LY 53857) or peripheral (xylamidine) 5-HT2 antagonists. Prazosin did not alter the AP or HR response to DOI. Chlorisondamine abolished the bradycardia but slightly increased the hypertension produced by DOI, while enalapril attenuated the pressor response. No further reduction was produced by the combination of enalapril and prazosin. Propranolol attenuated but did not eliminate the renin response, and blocked the bradycardia elicited by DOI. The data suggest that DOI activates 5-HT2 receptors located on vascular smooth muscle and/or the circumventricular organs of the brain to: (1) increase AP and reflexly decrease HR, (2) decrease RBF and (3) increase PRA. The hypertension is mediated by angiotensin II and direct vascular effects whereas the increase in PRA is mediated by an interaction of increased sympathetic nerve activity and decreased renal perfusion pressure.


Jul 31, 1979·Naunyn-Schmiedeberg's Archives of Pharmacology·M Göthert, U Dührsen
Jan 1, 1978·Naunyn-Schmiedeberg's Archives of Pharmacology·J R Fozard, A T Ali
Jan 1, 1990·Journal of Cardiovascular Pharmacology·M H ZinkR H Alper
Sep 1, 1986·Kidney International·J L BlackshearN K Hollenberg
Jun 22, 1988·European Journal of Pharmacology·R B McCall, L T Harris
Jan 1, 1987·Journal of Medicinal Chemistry·R A Glennon
Apr 8, 1967·Nature·F C CoppM F Sim

❮ Previous
Next ❯


Aug 1, 1994·Aging : Clinical and Experimental Research·L W DavidowR D Buñag
Nov 6, 1990·European Journal of Pharmacology·T ShojiY Abe
Feb 14, 1991·European Journal of Pharmacology·T TakahashiS Satoh
Oct 6, 1992·European Journal of Pharmacology·A D LevyL D Van de Kar
Jul 1, 1992·Pharmacology, Biochemistry, and Behavior·A D LevyL D Van de Kar
Jan 1, 1996·Behavioural Brain Research·L D Van de KarA D Levy
Mar 10, 2004·Pharmacology, Biochemistry, and Behavior·Kuldip D DaveVincent J Aloyo
Jan 16, 2002·European Journal of Pharmacology·Ruben D BuñagJennifer R Mellick
Aug 2, 2002·Pharmacology, Biochemistry, and Behavior·Mike F HawkinsThomas S Guillot
Feb 1, 1993·Kidney International·K EndlichM Steinhausen
Mar 4, 2008·Stress : the International Journal on the Biology of Stress·Youichirou OotsukaEugene Nalivaiko
Jan 1, 1991·Journal of Psychopharmacology·M SkingleW Feniuk

❮ Previous
Next ❯

Related Concepts

Related Feeds


Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.